PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
TIL vs. SMMT
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between TIL and SMMT is 0.20, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

TIL vs. SMMT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Instil Bio, Inc. (TIL) and Summit Therapeutics Inc. (SMMT). The values are adjusted to include any dividend payments, if applicable.

-100.00%0.00%100.00%200.00%300.00%400.00%SeptemberOctoberNovemberDecember2025
-95.79%
255.96%
TIL
SMMT

Key characteristics

Sharpe Ratio

TIL:

0.62

SMMT:

1.58

Sortino Ratio

TIL:

2.53

SMMT:

5.12

Omega Ratio

TIL:

1.30

SMMT:

1.67

Calmar Ratio

TIL:

0.92

SMMT:

5.54

Martin Ratio

TIL:

2.24

SMMT:

16.94

Ulcer Index

TIL:

40.21%

SMMT:

27.80%

Daily Std Dev

TIL:

145.71%

SMMT:

298.22%

Max Drawdown

TIL:

-98.83%

SMMT:

-95.75%

Current Drawdown

TIL:

-95.89%

SMMT:

-32.67%

Fundamentals

Market Cap

TIL:

$145.27M

SMMT:

$15.86B

EPS

TIL:

-$11.56

SMMT:

-$0.23

Total Revenue (TTM)

TIL:

$0.00

SMMT:

$0.00

Gross Profit (TTM)

TIL:

-$1.99M

SMMT:

-$67.00K

EBITDA (TTM)

TIL:

-$53.61M

SMMT:

-$151.48M

Returns By Period

In the year-to-date period, TIL achieves a 16.61% return, which is significantly lower than SMMT's 20.48% return.


TIL

YTD

16.61%

1M

8.01%

6M

88.01%

1Y

89.61%

5Y*

N/A

10Y*

N/A

SMMT

YTD

20.48%

1M

17.87%

6M

106.43%

1Y

454.12%

5Y*

69.13%

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

TIL vs. SMMT — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TIL
The Risk-Adjusted Performance Rank of TIL is 7878
Overall Rank
The Sharpe Ratio Rank of TIL is 6969
Sharpe Ratio Rank
The Sortino Ratio Rank of TIL is 8888
Sortino Ratio Rank
The Omega Ratio Rank of TIL is 8484
Omega Ratio Rank
The Calmar Ratio Rank of TIL is 7878
Calmar Ratio Rank
The Martin Ratio Rank of TIL is 6969
Martin Ratio Rank

SMMT
The Risk-Adjusted Performance Rank of SMMT is 9696
Overall Rank
The Sharpe Ratio Rank of SMMT is 8989
Sharpe Ratio Rank
The Sortino Ratio Rank of SMMT is 9898
Sortino Ratio Rank
The Omega Ratio Rank of SMMT is 9898
Omega Ratio Rank
The Calmar Ratio Rank of SMMT is 9898
Calmar Ratio Rank
The Martin Ratio Rank of SMMT is 9797
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

TIL vs. SMMT - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Instil Bio, Inc. (TIL) and Summit Therapeutics Inc. (SMMT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for TIL, currently valued at 0.62, compared to the broader market-2.000.002.000.621.58
The chart of Sortino ratio for TIL, currently valued at 2.53, compared to the broader market-4.00-2.000.002.004.002.535.12
The chart of Omega ratio for TIL, currently valued at 1.30, compared to the broader market0.501.001.502.001.301.67
The chart of Calmar ratio for TIL, currently valued at 0.92, compared to the broader market0.002.004.006.000.926.57
The chart of Martin ratio for TIL, currently valued at 2.24, compared to the broader market0.0010.0020.0030.002.2416.94
TIL
SMMT

The current TIL Sharpe Ratio is 0.62, which is lower than the SMMT Sharpe Ratio of 1.58. The chart below compares the historical Sharpe Ratios of TIL and SMMT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.004.005.006.00SeptemberOctoberNovemberDecember2025
0.62
1.58
TIL
SMMT

Dividends

TIL vs. SMMT - Dividend Comparison

Neither TIL nor SMMT has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

TIL vs. SMMT - Drawdown Comparison

The maximum TIL drawdown since its inception was -98.83%, roughly equal to the maximum SMMT drawdown of -95.75%. Use the drawdown chart below to compare losses from any high point for TIL and SMMT. For additional features, visit the drawdowns tool.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2025
-95.89%
-32.67%
TIL
SMMT

Volatility

TIL vs. SMMT - Volatility Comparison

Instil Bio, Inc. (TIL) has a higher volatility of 36.00% compared to Summit Therapeutics Inc. (SMMT) at 25.91%. This indicates that TIL's price experiences larger fluctuations and is considered to be riskier than SMMT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


20.00%40.00%60.00%80.00%100.00%SeptemberOctoberNovemberDecember2025
36.00%
25.91%
TIL
SMMT

Financials

TIL vs. SMMT - Financials Comparison

This section allows you to compare key financial metrics between Instil Bio, Inc. and Summit Therapeutics Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab